Wednesday, December 03, 2008 10:12:55 PM
"frogdreaming,"
That is an unfounded personal attack, which you well know I have previously refuted.
I have stated multiple times, that I have zero insider information. You repeatedly accuse me of having insider information, which of course, you have zero evidence of. You accusation is unfounded. I still have precisely zero insider (material nonpublic) information. For you to continue to insist otherwise, is nothing but an unfounded personal attack.
Also, look up the word, "evidence." What third parties (more than 30 distributors, news media, agencies, other companies,) disclose publicly about DNAPrint Genomics certainly _is_ evidence.
P.S., if you follow the links I gave here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=33933513
You can plainly see that some of the patent applications are listed with 2008 (current year) dates. That is where I got that information. I have been quite plain about the source of that information; I mentioned the current-year patent applications only in this context.
Cease and desist the repetitive, unfounded personal attacks. Thank you.
Daniel Gannon
Portland, Oregon, USA
(Possessor of Precisely ZERO Material Nonpublic Information Pertaining to DNAG)
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM